. 3

.

roxytryptamine and their antagonists. In: Pharmacologic Basis of Therapeutics, ed. by L. S. Goodman and A. Oilmert, pp. 590 629, MacMillan Publishing Co., Inc., New York, 1975.

286. Beaven M. A. Histamine, N. Engl. J. Med., 294, 3036 (1976).

287. Plaut M. Histamine, Hj and H2 antihistamines and immediate hypersensitivity reactions, J. Allergy Clin. Invest., 63, 371375 (1979). . .

288. L., Hjerten S. Histamine Metabolism. Purification and immunochemical analysis of histidine decarboxylase from murine mastocytoma, Agents Actions, 10, 9293 (1980).

289. Uvnas B. Quantitative correlation between degranulation and histamine release in mast cells. In: Biochemistry of the Acute Allergic Reactions: Second International Symposium, ed. by K. F. Austen and E. L. Becker, pp. 175188, Blackwell, Oxford, 1979.

290. Kruger P. G., Lagunojf D. Mast cell restoration: A study of the rat peritoneal mast cells after depletion with polymyxin B. Int. Arch. Allergy Appl. Immunol., 65, 278290 (1981).

291. Beall G. N., VanArsdel P. P., Jr. Histamine metabolism in human disease, J. Clin. Invest., 39, 676683 (I960).

292. Smith P. L., Kagly-Sobotka A., Blieckes E. R., Traystman R., Kaplan A. P., Gralnick H., Valentine M. D., Permutt S., Lichtenstein L. M. Physiologic manifestations of human anaphylaxis, J. Clin. Invest., 66, 10721080 (1980).

293. Platshon L., Kaliner M. The effects of the immunologic release of histamine upon human lung cyclic nucleotide levels and prostaglandin generation, J. Clin. Invest., 62, 1113 1121 (1978).

294. Rocklin R. E. Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes, J. Clin. Invest., 57, 10511058 (1976).

295. Rocklin R. E., Greineder D. K., Melmon K. L. Histamine-induced supressor factor (HSF): Further studies on the nature of the stimulus and the cell which produces it, Cell Immunol., 44, 404-415 (1979).

296. Plaut M., Lichtenstein L. M., Gillespie E., Henney . S. Studies on the mechanism of lymphocyte-mediated cytolysis. IV. Specificity of the histamine receptor on effector T cells, J. Immunol., Ill, 389-394 (1973).

297. Bourne H. R., Melmon K. L., Lichtenstein L. M. Histamine augments leukocyte cyclic AMP and blocks antigenic histamine release, Science, 173, 743745 (1971).

298. Sosman J., Busse W. Histamine inhibition of neutrophil lysosomal enzyme release: An H2 histamine receptor source, Science, 194, 737738 (1976).

299. Gallin J. I., Weinstein A. M., Cramer E. ., Kaplan A. P. Histamine modulation of human eosinophil locomotion in vitro and in vivo. In: The Eosinophil in Health and Disease, ed. by A. A. F. Mahmond and K. F. Austen, pp. 185206, Grune and Stratton, New York, 1980.

300. Rosner I. K., Colten H. ., Edelson P. J. Human monocytes have binding sites for histamine. Presented at the 1979 Conference of the Society for Pediatric Research, Atlanta, Georgia, 1979.

301. Osband M., McCaffrey R. Solubilization, separation and partial characterization of histamine Ht and H2 receptors from calf thymocyte membranes, J. Biol. Chem., 254, 9970 9972 (1979).

302. Rocklin R. E. Histamine-induced supressor factor (HSF): Effect on migration inhibitory factor (MIF) production and proliferation, J. Immunol. 118, 17341738 (1977).

303. Polmar S. H., Birch R. E. Regulation of Fc receptor expression on T-lymphocyte subsets mediated by adenosine and histamine receptors. In: Immunoregulation and Autoimmunity, ed. by R. S. Krakauer and M. K. Cathcart, pp. 1120, Elsevier/North Holland, New York, 1980.

304. Birch R. E., Polmar S. H. Induction of Fey receptors on a subpopulation of human T lymphocytes by adenosine and impromide, an H,-histamine agonist, Cell. Immunol. 57, 455-467 (1981).

305. Lichtenstein L. M., Gillespie E. The effects of the Hj and H2 antihistamines on allergic histamine release and its inhibition by histamine, J. Pharm. Exp. Ther., 192, 441450 (1975).

306. Dy M., Lebel ., Kamoun P., Bamberger J. Histamine production during the anti-allograft response. Demonstration of a new lymphokine enhancing histamine syntesis, J. Exp. Med., 153, 293-309 (1981).

307. Dy M., Lebel B. Production d'histamine et du facteur stimulant des cellules productrices d'histamine (HCSAF) par des leucocytes incubes avec la concanavalin A. Effect d'une pre-sensibilisation par une allogreffe de pear, C.R. Acad. Sci. Paris, 393, 399402 (1981).

308. Ward O. A., Dvorak H. F., Cohen S., Yashida ., Data R., Selvaggio S. S. Chemotaxis of basophils by lymphocyte-dependent and lymphocyte-independent mechanisms, J. Immunol. 114, 15231531 (1975).

309. Left-Brown M. A., Boetchr N. A., Leonard E. J. Chemotactic response of normal human basophils to C5a and to lymphocyte-derived chemotactic factor, J. Immunol., 117 246 252 (1976).

310. Page I. H. Serotonin, Yearbook Medical Publishers, Chicago, 1968.

27. : 311. Brocklehurst W. . Slow reacting substance and related compounds, Prog. Allergy, 6, 539558 (1958).

312. Askenase P. W., Bursziajn S., Gershon M. D., Gershon R. . T cell dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity, J. Exp. Med. 152, 1358-1374 (1980).

313. Sandler J. A., Clyman R. I., Manganiello V. C, Vaughn M. The effect of serotonin (5-hydroxytryptamine) and derivatives on guanosine 3'5'-monophosphate in human monocytes, J. Clin. Invest., 55, 431-435 (1975).

314. Foon K. A., Wahl S. M., Oppengeim J. ./., Rosenstreich D. L. Serotonin-induced production of a monocyte chemotactic factor by human peripheral blood leukocytes, J. Immunol., 7, 1545-1552 (1976).

315. Linthicum D. S., Frelinger J. A. Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H2 and histamine sensitization genes, J. Exp. Med., 155, 3140 (1982).

316. Fernandez II. N., Hugli . E. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin, J. Biol. Chem., 253, 69556962 (1978).

317. Gerard C., Chenoweth D. E., Hugli . E. Response of human neutrophils to C5a: A role for the oligosaccharide moiety of human C5adesArg_74 but not of C5a in biologic activity, J Immunol., 127, 1978 1982 (1981).

318. Chenoweth D., Hugli . E. Demonstration of specific C5a and C5a analogs as probes of the neutrophil C5a receptor, Mol. Immunol., 17, 151156 (1978).

319. Chenoweth D. E., Hugli . E. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes, Proc. Natl. Acad. Sci. USA, 75, 39433947 (1978).

320. Atkinson J. P., Frank M. Complement. In: Clinical Immunology, ed. by C. W. Parker, pp. 219271, W. B. Saunders, Philadelphia, 1980.

321. Cochrane C. G., Muller-Eberhard H. J. The derivation of the two distinct anaphylatoxin activities from the third and fifth components of human complement, J. Exp. Med., 127, 371386 (1968).

322. Dupree E., Goldman A. S.. Grant J. A. Complement-mediated release of histamine from human leukocytes, J. Allergy Clin. Immunol., 53, 75 (1974).

323. Petersson B. A., Nilsson A., Stalenheim G. Induction of histamine release and desensitiz-ation in human leukocytes. Effects of anaphylatoxins, J. Immunol., 114, 15811584 (1975).

324. Stimier N. P., Bach M. K., Bloor . M., Hugli . E. Release of leukotrienes from guinea pig lung stimulated by C5a des lArg anaphilotoxins, J. Immunol., 128, 22472251 (1982).

325. Regal J. F., Eastman A. Y., Pickering R. J. C5a induced tracheal contraction: A histamine independent mechanism, J. Immunol., 124, 28762878 (1980).

326. Vogt W., Zeman N., Garbe G. Histaminun-abhangige wirkungen von anaphylatoxin auf glatte muskulatur isolierter organe, Naunyn Schmiedebergs Arch. Pharmacol., 262, 399 404 (1969).

327. Hugli T. E., Erickson B. W. Synthetic peptides with the biological activities and specifity of human C3q anaphylatoxin, Proc. Natl. Acad. Sci. USA, 74, 18261830 (1977).

328. Vogt W. Preparation and some properties of anaphylotoxin from hog serum, Biochem. Pharmacol., 17, 727733 (1968).

329. Meuer S., Ecker U., Haddine U., itter-Snermann D. Platelet-serotonin release by and C5a: Two independent pathways of activation, J. Immunol., 126, 15061509 (1980).

330. ter Laan ., Moleanaar J. L., Feltkamp-Vroom . M., Pondman K. W. Interaction of human anaphylatoxin with rat mast cells demonstrated by immunofluorescence, Eur. J. Immunol., 4, 393395 (1974).

331. Babior G. L., Rosin R. E., McMurrich B. J., Peters W. A., Babior . M. Arrangement of the respiratory burst oxidase in the plasma membrane of the neutrophil, J. Clin. Invest., 67, 1724 1728 (1981).

332. Lew P. D., Stossel T. P. Effect of calcium on superoxide production by phagocytic vesicles from rabbit alveolar macrophages, J. Clin. Invest. 67, 19 (1981).

333. McPhail L. C, Henson P. /., Johnson R. ., Jr. Respiratory bursts enzyme in human neutrophils. Evidence for multiple mechanisms of activation. J. Clin. Invest., 67, 710 716 (1981).

334. Haber F., Weiss J. The catalytic decomposition of hydrogen peroxide to iron salts, Proc. R. Soc. Lond. A. 147, 332351 (1934).

335. Johnson K. J., Ward P. W. Role of oxygen metabolites in immune complex injury of lung, J. Immunol., 126, 2365-2369 (1981).

336. Weiss S. /., Young^ J., LoBuglio A. F..- Slivka A., Nimeh N. F. Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells, J. Clin. Invest., 68. 714-721 (1981). . .

337. Till G. ., Johnson . J., Kunkel ., Ward P. A. Intravascular activation of complement and acute lung injury, J. Clin., Invest., 69, 11261135 (1982).

338. Rosen ., Klebanoff S. J. Hydroxyl radical generation by polymorphonuclear leukocytes measured by electron spin resonance spectroscopy, J. Clin. Invest., 64, 17251729 (1979).

339. Repine J. E., Eaton J. W., Anders M.

78
< > 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121

". 3" (4.83Mb)


[]  []  [ ]  [ ]


Rambler's Top100

Copyright 2009
(24.07.2017)